Patient Inclusion Completed for Cardiawave’s “Valvosoft® Pivotal Study”!
July 17th 2023
📢 Patient Inclusion Completed for Cardiawave’s “Valvosoft® Pivotal Study”! 🎉
Cardiawave has reached a major milestone in its journey, the patient enrollment is now officially completed with our last 2 patients treated last week in OLVG ((Amsterdam, Netherlands) – thanks to Dr Robert Riezebos, Dr Giovanni Amoroso and team, and Dr Anthonie (Toon) Duijnhouwer, MD, PhD (proctor) ! 🙌
Over the past months, our dedicated team of researchers, healthcare professionals, and patient volunteers have worked tirelessly to gather invaluable data and insights. Their commitment and contributions have been instrumental in advancing medical knowledge and pushing the boundaries of innovation in cardiology.
Our « Prospective, Single-arm Pivotal Study for the Treatment of Subjects with Severe Symptomatic Calcific Aortic Valve Stenosis Using Valvosoft® Non-Invasive Ultrasound Therapy (NIUT) » has been an incredible opportunity to evaluate the safety and effectiveness of our NIUT medical device. The data collected will play a vital role in shaping the future of patient care regarding aortic stenosis. We look forward to continue our journey to bring this innovative therapy into the therapeutic options available all over the world.
Thanks to all the patients who participated in this study. Your willingness to be part of this important research will make a significant difference in the treatment of this lethal disease.
Thanks to all our partners, healthcare institutions, and the entire Cardiawave team for their dedication and tireless efforts in making this study a reality. It is through collaboration and collective commitment that we achieve remarkable milestones like this.
CHU de Reims CHU de Rouen CHU de Lille CLINIQUE PASTEUR Toulouse #hopitalbichat #HEGP AP-HP, Assistance Publique – Hôpitaux de Paris Radboudumc OLVG Amphia Ziekenhuis Kerckhoff-Klinik GmbH Marienkrankenhaus
Physics for Medicine Paris, #InstitutLangevin, CNRS – Centre national de la recherche scientifique, ESPCI Paris – PSL, Inserm RHU STOP AS
#HeartValveDisease #FocusedUltrasound #MedTech #AorticStenosis #Medtech #FrenchCare #Health20 #clinicalstudy